- Lucentis:
- For the treatment of patients with Neovascular (Wet) Age-Related Macular Degeneration (AMD)
- For the treatment of patients with Macular Edema Following Retinal Vein Occlusion
- For the treatment of patients with Diabetic Macular Edema
- Diabetic Retinopathy in patients with DME
- Eylea
- For the treatment of patients with Neovascular (Wet) Age-Related Macular Degeneration
- For the treatment of patients with Macular Edema Following Retinal Vein Occlusion (RVO)
- For the treament of patients with Diabetic Macular Edema
- Diabetic Retinopathy in patients with DME
- Macugen
- For the treatment of patients with Neovascular (Wet) Age-Related Macular Degeneration
- Visudyne
- For the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia or presumed ocular histoplasmosis.
Coverage of drugs is first determined by the member’s pharmacy or medical benefit. Please consult with or refer to the Evidence of Coverage document.